AzTrials
AzTrials

Molar Incisor HypomineralizationNCT07052019

Pain Perception and Anxiety With Virtual Reality vs Tell-Show-Do in Children With MIH

A study testing Virtual Reality Distraction and Tell-Show-Do Technique in people with Molar Incisor Hypomineralization, run by Cairo University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This pilot crossover randomized clinical trial aims to compare the effect of distraction using Virtual Reality (VR) versus the Tell-Show-Do (TSD) technique on pain perception and anxiety in children aged 6-12 with Molar Incisor Hypomineralization (MIH) undergoing restorative dental treatment. Read more about this study

Who is it for?
Ages 6 to 12 years
Conditions the study is for
Molar Incisor Hypomineralization
What is being tested?
Virtual Reality Distraction and Tell-Show-Do Technique
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteEgypt
Study dates
1 Aug 2025to 1 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children aged between 6-12 years.
  • Patients with two First Permanent molars diagnosed with MIH indicated for class I cavities.
  • A cooperative and compliant patient/ parent.
  • Patients not allergic to medicaments necessary to complete the procedure.
  • Patients with no history of chronic systemic diseases.

Who cannot join

  • MIH-affected molars require apexogenesis, apexification, regeneration or RCT.
  • Non-restorable tooth.
  • Previous restorative treatment.
  • Periodontally affected.
  • Children having systemic disease, an emotional behavioural or learning disorder.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Egypt1 site
  • faculty of dentistry, Cairo university

    Giza, Giza Governorate, 12611

    Hagar Saleem Hagar Saleem Mojahed Aboumusallam, Master degree, 00201110646161, hagarsaleem@gmail.com

    hagar saleem Hagar Saleem Mojahed Aboumusallam, master degree

Other trials in Egypt

About this study

Official title: Pain Perception and Anxiety With Virtual Reality Distraction Versus Tell-Show-Do Technique in Restorative Treatment for Children With Molar Incisor Hypomineralization: A Pilot Crossover Randomized Clinical Trial

This pilot crossover randomized clinical trial aims to compare the effect of distraction using Virtual Reality (VR) versus the Tell-Show-Do (TSD) technique on pain perception and anxiety in children aged 6-12 with Molar Incisor Hypomineralization (MIH) undergoing restorative dental treatment.

Read the detailed description

Molar Incisor Hypomineralization is a prevalent developmental condition affecting the enamel of first permanent molars and, occasionally, incisors. It presents significant clinical challenges due to the hypersensitivity and increased pain perception in affected teeth, which can make restorative treatment especially distressing for pediatric patients. Children with MIH are often apprehensive toward dental procedures, resulting in higher levels of dental anxiety that can impact their cooperation and the overall success of treatment. The management of pain and anxiety during restorative treatments is therefore crucial, particularly in this vulnerable population.

Behavioral management techniques, such as the Tell-Show-Do (TSD) approach, have been widely used in pediatric dentistry to alleviate anxiety and improve patient cooperation. However, recent advances in digital technology, particularly Virtual Reality (VR), offer novel, immersive forms of distraction that could enhance pain management by shifting the child's attention away from the dental procedure. VR distraction has shown promise in reducing anxiety and pain perception across various medical and dental settings, but its efficacy compared to traditional behavioral techniques, such as TSD, remains under-explored, especially in the context of MIH.

A recent systematic reviews of behavioral interventions in pediatric dentistry highlighted a lack of robust evidence regarding the effectiveness of VR as a distraction technique in dental settings, particularly in randomized controlled trials (RCTs). The reviews specifically called for more rigorous studies to directly compare VR with established techniques like TSD in managing dental anxiety and pain perception. Given this identified gap in the literature, this study aims to address these limitations by conducting a crossover randomized clinical trial to compare VR distraction with TSD in children with MIH undergoing restorative treatment. By examining both pain perception and anxiety levels, this study seeks to contribute valuable insights into the comparative effectiveness of VR and TSD, providing evidence-based recommendations for pediatric dental practitioners.

Being tested
Virtual Reality Distraction, Tell-Show-Do Technique
Keywords
Molar Incisor hypomineralization, MIH, virtual reality, behavioral, pain, anxiety
Medical subject headings
Molar Hypomineralization, Behavior, Pain, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality DistractionDevice

    Children wear virtual reality glasses during restorative dental treatment to reduce pain and anxiety.

  • Tell-Show-Do TechniqueBehavioural

    Conventional behavioral technique where the dentist tells, shows, and then performs the procedure to reduce anxiety and build cooperation.

Study groups in NCT07052019
Study groupRoleWhat they receive
Arm A: Virtual Reality then Tell-Show-DoExperimentalChildren receive restorative treatment with Virtual Reality distraction during the first session, and Tell-Show-Do technique during the second session (after washout period).
Receives: Device: Virtual Reality Distraction; Behavioral: Tell-Show-Do Technique
Arm B: Tell-Show-Do then Virtual RealityActive comparatorChildren receive restorative treatment with Tell-Show-Do technique in the first session, and Virtual Reality distraction in the second session (after washout period).
Receives: Device: Virtual Reality Distraction; Behavioral: Tell-Show-Do Technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain perception

    Tool: Wong Baker Faces Pain Rating Scale Unit: Score 0-10

    Measured: Immediately before treatment (baseline), during treatment (within session), and immediately after treatment (post-procedure)

Secondary outcomes (3)
  1. Anxiety level

    Tool: Modified Child Dental Anxiety Scale (MCDAS-f) Unit: Score 8-40

    Measured: Immediately before treatment (baseline), during treatment (within session), and immediately after treatment (post-procedure)

  2. Heart Rate

    Tool: Pulse Oximeter Unit: Beats per minute

    Measured: Baseline (5 minutes before session), during treatment (real-time), and immediately post-treatment (within 5 minutes)

  3. Oxygen Saturation

    Tool: Pulse Oximeter Unit: %

    Measured: Baseline (5 minutes before session), during treatment (real-time), and immediately post-treatment (within 5 minutes)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jul 2025
  2. Study start1 Aug 2025 (estimated)
  3. Primary completion1 Oct 2025 (estimated)
  4. Study completion1 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07052019
Sponsor's protocol ID
U Cairo Hagar
Status last verified
Jun 2025
First submitted
18 Jun 2025
Last updated
4 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality Distraction and Tell-Show-Do Technique in people with Molar Incisor Hypomineralization, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 4 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain perception (time frame: Immediately before treatment (baseline), during treatment (within session), and immediately after treatment (post-procedure)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in